• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Expand Collaboration to Include Clinical Study of Cannabidiol in Early Psychosis

    Jocelyn Aspa
    Sep. 04, 2018 08:42AM PST
    Cannabis Investing News

    INSYS Therapeutics (NASDAQ:INSY) has announced that its clinical development collaboration with the Center for Medicinal Cannabis Research (CMCR) at UC San Diego School of Medicine has expanded to include a new study to explore the effectiveness of its proprietary cannabidoil (CBD) oral solution in early psychosis. As quoted in the press release: The two organizations …

    INSYS Therapeutics (NASDAQ:INSY) has announced that its clinical development collaboration with the Center for Medicinal Cannabis Research (CMCR) at UC San Diego School of Medicine has expanded to include a new study to explore the effectiveness of its proprietary cannabidoil (CBD) oral solution in early psychosis.

    As quoted in the press release:

    The two organizations announced their collaboration in April with plans for a CMCR study of CBD from INSYS in pediatric patients with autism. As part of the collaboration, INSYS has agreed to provide its proprietary formulation of pharmaceutical-grade CBD oral solution for both CMCR studies, which are expected to start in 2019, with others under consideration.

    “As a result of this new study announced today, we expect to learn whether CBD reduces symptoms and improves cognition in early psychosis,” said Kristin Cadenhead, MD, professor of psychiatry at UC San Diego. “In addition, we plan to explore the effect of CBD on the biological response to psychosocial stress, and the effect of CBD on the eating behavior induced by antipsychotic medication.” CMCR Director Igor Grant, MD, added: “Cannabinoids such as CBD deserve rigorous study into their possible value in the treatment of neuropsychiatric disorders. We are pleased that through our collaboration with INSYS we have an opportunity to advance the field.”

    Click here to read the full press release.

    nasdaq:insycannabis investinginsys therapeutics
    The Conversation (0)

    Go Deeper

    AI Powered
    Person touching a cannabis plant; Australia map in flag colours.

    ASX Cannabis Stocks: 10 Biggest Companies in 2025

    australian dollar bills with jar of cannabis flower on table

    Top 3 ASX Cannabis Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×